News Multi-Tissue Organoid Better Predicts Human Response to Drug Treatments: CellCipher CellCipher has developed a new type of organoid model that captures nearly 70 different cell types to enable drug discovery and personalized medicine. In vitro human models, including organoids and...
News 10 Teams Participate in Polsky’s Spring 2022 I-Corps Program to Refine Market Fit for Novel Tech Ten teams from across the University of Chicago were selected to participate in the spring 2022 I-Corps program with the goal of determining the commercial potential of their technologies. Supported...
News Two UChicago Startups Receive Investment from the George Shultz Innovation Fund The George Shultz Innovation Fund (fall 2023 cycle) has awarded $200,000 to NetMicroscope and $150,000 to CellCipher to further develop their work. Managed by the Polsky Center for Entrepreneurship and...
News Life Sciences Community Convenes at Chicago BioCapital Summit in a Showcase of Local Innovation Hosted by the Chicago Biomedical Consortium (CBC), the inaugural Chicago BioCapital Summit this week brought together industry, academia, and investors in a showcase of the latest innovations in the life...
News Life Sciences, Tech Startups Advance to Fall 2023 George Shultz Innovation Fund Finals Researchers have developed a proprietary machine learning approach, multi-tissue human organoid model, and a targeted drug delivery method – and will be seeking investment at the fall 2023 George Shultz...
Page Health & Life Sciences Novel treatments, medical devices, diagnostics, and research tools spanning a range of therapeutic areas.
News Winter Collaboratorium to Feature Research from Across the Data Science Institute, Biological Sciences Division, and Pritzker School of Molecular Engineering The Collaboratorium unites University of Chicago students with researchers and faculty who are exploring commercialization opportunities for their work. The program provides the opportunity for scientists and researchers who want...
